Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Jian Aikang Concentrated Pill** is an oral traditional Chinese multi-herb medicine formula investigated in China as part of syndrome-differentiated traditional Chinese medicine interventions intended to delay disease progression in people with HIV infection. A registered prospective trial sponsored by The First Affiliated Hospital of Henan University of Chinese Medicine included Jian Aikang Concentrated Pill alongside Yiaikang Capsule and Tangcao Tablet. Preclinical network-pharmacology and HIV-pseudovirus-infected MT-4 cell studies proposed immunomodulatory and anti-inflammatory effects, including modulation of IL-1 alpha and IL-6 expression; however, its specific active ingredients, direct molecular targets, clinical efficacy, regulatory status, and manufacturer were not established by the available public sources. ([chictr.org.cn](https://www.chictr.org.cn/showproj.html?proj=30790))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jian Aikang Concentrated Pill.